Talk Evidence - Z drugs, subclinical hypothyroidism and Drazen’s dozen - podcast episode cover

Talk Evidence - Z drugs, subclinical hypothyroidism and Drazen’s dozen

Jun 25, 201945 min
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

This week on the podcast, (2.02) a listener asks, when we suggest something to stop, should we suggest an alternative instead? (8.24) Helen tells us to stop putting people on treatment for subclinical hypothyroidism, but what does that mean for people who are already receiving thyroxine? (20.55) Carl has a black box warning about z drugs, and wonders what the alternative for sleep are. (30.11) Finally the NEJM has published Jeff Drazen's dozen most influential papers - but not a systematic review amongst them. Cue the rant. Reading list: Rapid rec on subclinical hypothyroidism https://www.bmj.com/content/365/bmj.l2006 Temporal trends in use of tests in UK primary care, 2000-15 https://www.bmj.com/content/363/bmj.k4666 Black box warning for z-drugs https://www.bmj.com/content/365/bmj.l2165 Drazen's dozen

https://cdn.nejm.org/pdf/Drazens-Dozen.pdf

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Talk Evidence - Z drugs, subclinical hypothyroidism and Drazen’s dozen | Medicine and Science from The BMJ podcast - Listen or read transcript on Metacast